To investigate the interaction between eribulin and STING agonists, we first determined the time-dependent expression of IFNβ in the human monocytic leukemia cell line THP-1 after transfection with HT-DNA as a mechanism to increase cytosolic DNA and promote STING activation. The gene discussed is STING1; the disease is monocytic leukemia.